Neurogene Price Chart
Neurogene Volume Chart
Neurogene Market Segments
Overnight
*No Trades in Segment
After Hours
+0.16(+0.50%)
| Open | $32.25 |
|---|---|
| Close | $32.41 |
| Low | $32.25 |
| Low Change | 0.00 (0.00%) |
| High | $32.41 |
| High Change | +0.16 (+0.50%) |
| Range | $0.16 |
| Volume | 24.133K |
| Dollar Volume | $782.15K |
Regular Trading Hours
+0.09(+0.28%)
| Open | $32.11 |
|---|---|
| Close | $32.20 |
| Low | $31.45 |
| Low Change | -0.66 (-2.06%) |
| High | $32.97 |
| High Change | +0.86 (+2.66%) |
| Range | $1.52 |
| Volume | 140.283K |
| Dollar Volume | $4.52M |
Premarket
+0.21(+0.66%)
| Open | $32.00 |
|---|---|
| Close | $32.21 |
| Low | $32.00 |
| Low Change | 0.00 (0.00%) |
| High | $32.21 |
| High Change | +0.21 (+0.66%) |
| Range | $0.21 |
| Volume | 420 |
| Dollar Volume | $13.53K |
After Hours Yesterday
+0.00(+0.00%)
| Open | $31.53 |
|---|---|
| Close | $31.53 |
| Low | $31.53 |
| Low Change | 0.00 (0.00%) |
| High | $31.53 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 158.693K |
| Dollar Volume | $5.00M |
Regular Trading Hours Yesterday
+0.14(+0.43%)
| Open | $31.46 |
|---|---|
| Close | $31.60 |
| Low | $31.03 |
| Low Change | -0.43 (-1.37%) |
| High | $32.50 |
| High Change | +1.04 (+3.31%) |
| Range | $1.47 |
| Volume | 136.848K |
| Dollar Volume | $4.32M |
Premarket Yesterday
*No Trades in Segment
Neurogene News
Neurogene Top Trades
Neurogene's top trade so far today returned +3.05%, while the top short trade returned -2.36%.
Neurogene Moving Averages
| 5 Day Moving Average (SMA5) | $30.77 |
|---|---|
| 10 Day Moving Average (SMA10) | $29.73 |
| 20 Day Moving Average (SMA20) | $28.43 |
| 50 Day Moving Average (SMA50) | $27.86 |
| 100 Day Moving Average (SMA100) | $23.88 |
| 200 Day Moving Average (SMA200) | $23.17 |
Neurogene Statistics
| Average Volume (30 Days) | 149.94K |
|---|---|
| P/E Ratio (Current) | -5.05 |
| EPS (Current) | -$6.24 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$83.20M |
| Cash Ratio | 6.58 |
| Current Ratio | 13.08 |
| Quick Ratio | 13.08 |
| Debt to Equity | 0.00 |
| Enterprise Value | $374.09M |
| EV to EBITDA | -3.48 |
| EV to Sales | — |
| Price to Book | 2.10 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.37% |
| Return on Equity | -0.41% |
Neurogene Stock Splits
There has been 1 stock split for Neurogene (NGNE). The reverse stock split occured on September 25, 2023 and reduced the outstanding shares at a ratio of 5:1.
| Date | Type | Ratio |
|---|---|---|
| Sep 25, 2023 | Reverse | 5:1 |
Neurogene Dividends
There have been no dividends for Neurogene (NGNE).